EFM
E Fund Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
10,131
+586
| +6% | +$16.9K | 0.01% | 312 |
|
|
2025
Q1 | $320K | Buy |
9,545
+3,770
| +65% | +$126K | 0.02% | 299 |
|
|
2024
Q4 | $295K | Sell |
5,775
-487
| -8% | -$24.9K | 0.01% | 318 |
|
|
2024
Q3 | $320K | Sell |
6,262
-551
| -8% | -$28.2K | 0.02% | 248 |
|
|
2024
Q2 | $305K | Sell |
6,813
-3,435
| -34% | -$154K | 0.02% | 229 |
|
|
2024
Q1 | $480K | Sell |
10,248
-2,821
| -22% | -$132K | 0.03% | 162 |
|
|
2023
Q4 | $465K | Buy |
13,069
+2,914
| +29% | +$104K | 0.03% | 176 |
|
|
2023
Q3 | $302K | Buy |
+10,155
| New | +$302K | 0.02% | 207 |
|